1995
DOI: 10.1038/bjc.1995.303
|View full text |Cite
|
Sign up to set email alerts
|

Carbogen breathing with nicotinamide improves the oxygen status of tumours in patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
9
0

Year Published

1996
1996
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(13 citation statements)
references
References 29 publications
1
9
0
Order By: Relevance
“…From a clinical standpoint, it is encouraging that the response to carbogen is observable in a primary tumour model (MNU-induced mammary adenocarcinoma) that arises from a single transformed cell. Significant increases in median pO2, measured by microelectrodes, in response to carbogen have been reported for a range of human tumours (Falk et al, 1992;Laurence et al, 1995) and data on 19 patients indicate that responses of human tumours to carbogen breathing can be satisfactorily monitored by GRE MRI (Taylor et al, 1996). This method may thus become a useful clinical tool in the assessment of patient treatment protocols by monitoring tumour blood flow and oxygenation noninvasively.…”
Section: Discussionmentioning
confidence: 99%
“…From a clinical standpoint, it is encouraging that the response to carbogen is observable in a primary tumour model (MNU-induced mammary adenocarcinoma) that arises from a single transformed cell. Significant increases in median pO2, measured by microelectrodes, in response to carbogen have been reported for a range of human tumours (Falk et al, 1992;Laurence et al, 1995) and data on 19 patients indicate that responses of human tumours to carbogen breathing can be satisfactorily monitored by GRE MRI (Taylor et al, 1996). This method may thus become a useful clinical tool in the assessment of patient treatment protocols by monitoring tumour blood flow and oxygenation noninvasively.…”
Section: Discussionmentioning
confidence: 99%
“…It has been used with or without nicotinamide, which can increase vascular perfusion. The ARCON protocol is currently being evaluated in the clinic and has been demonstrated to increase oxygenation and local control in these patients 94. Nonrandomized clinical studies showed promising results using the ARCON protocol.…”
Section: Treatments To Overcome or Exploit Hypoxiamentioning
confidence: 99%
“…The current study was perfonned using one extreme method, BBO, to introduce tumor hyper-oxygenafion. There are other methods, such as using normobaric oxygen/carbogen which may be more clinically applicable, for improving tumor oxygenation (21)(22)(23). The results of the present study warrant further investigation ofthese hyper-oxygenation techniques to improve tumor response to PDT.…”
Section: Discussionmentioning
confidence: 80%